AXT (AXTI) had the highest return between February 1, 2026 and March 31, 2026 by a mid-cap US stock, returning 211.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
AXT (AXTI) | 2/1/2026 - 3/31/2026 | 211.45% |
Applied Opt (AAOI) | 2/1/2026 - 3/31/2026 | 101.36% |
Sasol (SSL) | 2/1/2026 - 3/31/2026 | 88.65% |
Veradermics (MANE) | 2/1/2026 - 3/31/2026 | 85.74% |
Tango Therapeutics (TNGX) | 2/1/2026 - 3/31/2026 | 80.03% |
Valaris (VAL) | 2/1/2026 - 3/31/2026 | 75.38% |
Acadia Healthcare (ACHC) | 2/1/2026 - 3/31/2026 | 74.68% |
Par Pacific (PARR) | 2/1/2026 - 3/31/2026 | 72.56% |
SM Energy (SM) | 2/1/2026 - 3/31/2026 | 67% |
Kodiak Sciences (KOD) | 2/1/2026 - 3/31/2026 | 65.31% |
SolarEdge Technologies (SEDG) | 2/1/2026 - 3/31/2026 | 64.73% |
Calumet Specialty Products Partners (CLMT) | 2/1/2026 - 3/31/2026 | 62.96% |
Delek US Energy (DK) | 2/1/2026 - 3/31/2026 | 59.54% |
Spyre Therapeutics (SYRE) | 2/1/2026 - 3/31/2026 | 58.82% |
Dianthus Therapeutics (DNTH) | 2/1/2026 - 3/31/2026 | 57.6% |
Pulse Biosciences (PLSE) | 2/1/2026 - 3/31/2026 | 56.56% |
CVR Energy (CVI) | 2/1/2026 - 3/31/2026 | 55.76% |
Ichor (ICHR) | 2/1/2026 - 3/31/2026 | 55.73% |
Argan (AGX) | 2/1/2026 - 3/31/2026 | 55.3% |
Erasca (ERAS) | 2/1/2026 - 3/31/2026 | 54.39% |
Patterson-UTI Energy (PTEN) | 2/1/2026 - 3/31/2026 | 50.74% |
Chemours (CC) | 2/1/2026 - 3/31/2026 | 50.12% |
PBF Energy (PBF) | 2/1/2026 - 3/31/2026 | 49.38% |
Chord Energy (CHRD) | 2/1/2026 - 3/31/2026 | 49.06% |
Enliven Therapeutics (ELVN) | 2/1/2026 - 3/31/2026 | 48.99% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.